secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2023-11-22T23:59:59+00:00
Accession:  0001193125-23-282236
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

President Leonid Beigelman resigns; severance includes 6 months salary, 12 months COBRA
--------------------------------------------------------------------------------

- Dr. Leonid Beigelman, President, resigned effective Nov 20, 2023; entered into separation agreement.
- Separation agreement includes general release of claims and standard restrictive covenants.
- Severance includes 6 months of current base salary and COBRA continuation at company expense for 12 months.
- Agreement to be filed as exhibit to 2023 Form 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523282236/0001193125-23-282236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523282236/d589765d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-282236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer